MMP9 antibody - Aminoterminal end (ab38904)

Product Name 

MMP9 antibody - Aminoterminal end

Product type 

Primary antibodies

Description 

Rabbit polyclonal to MMP9 - Aminoterminal end

Immunogen 

Synthetic peptide based on the aminoterminal region of human MMP9.

(Peptide available as ab41068.)

Reacts with 
(species key)

Hu

Specificity 

This antibody recognizes MMP9, but does not cross react with the other MMP family members (MMP1, MMP2, MMP3, etc).

We have a range of domain specific antibodies for this target. For a full list please see all MMP9 antibodies

Tested applications 
(see key)

WB

Abreviews 

Customer reviews (see key)

Read about Abreviews

Application notes 
(see key)

Recommended dilutions
WB: Use at an assay dependent dilution. Predicted molecular weight: 78 kDa. When used against the reduced protein, ab38904 identifies bands at 92kDa and 88kDa (the pro form and active form respectively). Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Positive control 
(see definition)

WB: Human MMP9 and cell media from human chondrosarcoma (untreated).

Cellular localization 

Secreted; extracellular matrix

Research areas 

Cardiovascular >> Atherosclerosis >> Thrombosis >> Other
Cancer >> Tumor biomarkers >> Enzymes >> MMPs
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs
Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP
Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP

Relevance 

All cells within tissues are surrounded by an extracellular matrix (ECM) giving the tissues shape and structure. The ECM is constantly being remodeled and constant communication is maintained between cells through this matrix. Secreted proteins, termed matrix metalloproteinases (MMPs), are involved in the modulation of cell matrix interactions. MMPs are Zn(2+) binding endopeptidases that degrade various components of the ECM. MMPs are enzymes implicated in normal and pathologic tissue remodeling processes, wound healing, angiogenesis, and tumor invasion. These enzymes are very potent when active, and are associated with extracellular space inhibitors called TIMPs (tissue inhibitors of matrix metalloproteinases). TIMPs have been shown to block tumor cell invasion suggesting that they act as metastasis suppressor genes.

MMP9, also known as gelatinase B, is a secreted enzyme which degrades the interstitial collagens, types I, II, and III and is produced by normal alveolar macrophages and granulocytes. The expression of MMP9 increases in Epstein-Barr virus infected lymphoma derived cell lines and may be of significance in typically invasive nasopharyngeal carcinomas. MMP9 is constitutively produced by some tumor cell lines (e.g.: HT1080, HL60, U937) but not by most quiescent cells and tissues. Treatment of cells with the phorbol ester TPA stimulates production of MMP9 in some cell types, but the low protein levels produced (pg/ml) often require concentration of cell culture media to visualize the bands by Western blotting.

Database links 

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: Sodium Azide
Constituents: 50% Glycerol

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

See below for MMP9 antibody - Aminoterminal end images, references, products related to ab38904 and other tools.

MMP9 antibody - Aminoterminal end images:

References for MMP9 antibody - Aminoterminal end (ab38904)

  This product has been used in:

Pivot-Pajot C et al. Characterisation of degranulation and phagocytic capacity of a human neutrophilic cellular model, PLB-985 cells. Immunobiology 215:38-52 (2010). WB; Human. PubMed: 19250699

If you publish research using ab38904 please let us know so that we can cite the reference on this datasheet.

Customer reviews (feedback) regarding MMP9 antibody - Aminoterminal end

Customer FAQs regarding MMP9 antibody - Aminoterminal end

Protocols for MMP9 antibody - Aminoterminal end

Price and availability of products related to MMP9 antibody - Aminoterminal end

MMP9 antibody - Aminoterminal end - related products: